| IBD | Inflammatory bowel disease |
| PLA2 | phospholipase A2 |
| LPC | lysophosphatidylcholine |
| DMAP | 4-dimethylaminopyridine |
| TLC | thin-layer chromatography |
| DCC | N,N′-dicyclohexylcarbodiimide |
| HPLC | High-performance liquid chromatography |
| NMR | Nuclear Magnetic Resonance |
| IBD | Inflammatory bowel disease |
| PLA2 | phospholipase A2 |
| LPC | lysophosphatidylcholine |
| DMAP | 4-dimethylaminopyridine |
| TLC | thin-layer chromatography |
| DCC | N,N′-dicyclohexylcarbodiimide |
| HPLC | High-performance liquid chromatography |
| NMR | Nuclear Magnetic Resonance |